141 related articles for article (PubMed ID: 35068171)
1. The Correlation Between
Zhang J; Dong ZF; Bian CX; Zhang X; Xin XB; Chen F
Clin Appl Thromb Hemost; 2022; 28():10760296211073272. PubMed ID: 35068171
[TBL] [Abstract][Full Text] [Related]
2. A Study on the Correlation Between MDR1 Polymorphism and Clopidogrel Resistance in Hui Patients Treated with Percutaneous Coronary Intervention.
Chen F; Zhang J; Bian CX; Zhang J; Xin XB; Pan YY; Zhang X
Int J Gen Med; 2021; 14():665-671. PubMed ID: 33658839
[TBL] [Abstract][Full Text] [Related]
3. Distribution of CYP2C19, ABCB1 and PON1 polymorphisms in Chinese Han, Hui, Uygur and Kazak patients with coronary atherosclerotic heart disease.
Ma L; Yuan Y; Li J; Yu C; Zhao J
Int J Immunogenet; 2020 Dec; 47(6):539-545. PubMed ID: 32862511
[TBL] [Abstract][Full Text] [Related]
4. A SNP involved in alternative splicing of
Zhang S; Wang J; Zhang A; Zhang X; You T; Xie D; Yang W; Chen Y; Zhang X; Di C; Xie X
Aging (Albany NY); 2020 Nov; 12(24):25684-25699. PubMed ID: 33232268
[TBL] [Abstract][Full Text] [Related]
5. The risk of clopidogrel resistance is associated with ABCB1 polymorphisms but not promoter methylation in a Chinese Han population.
Su J; Yu Q; Zhu H; Li X; Cui H; Du W; Ji L; Tong M; Zheng Y; Xu H; Zhang J; Zhu Y; Xia Y; Liu T; Yao Q; Yang J; Chen X; Yu J
PLoS One; 2017; 12(3):e0174511. PubMed ID: 28358842
[TBL] [Abstract][Full Text] [Related]
6. Genetic determinants of high on-treatment platelet reactivity in clopidogrel treated Chinese patients.
Zhang L; Chen Y; Jin Y; Qu F; Li J; Ma C; Yang J; Xu B; Wang H; Li X; Li Y; Zhang Y; Lu C; Yin T
Thromb Res; 2013 Jul; 132(1):81-7. PubMed ID: 23726091
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between ATP-binding cassette subfamily B member 1 and cytochrome P450 2C19 polymorphisms and the effect of clopidogrel post percutaneous coronary intervention in patients with acute coronary syndrome].
Zhou CF; Ren YH; Song YQ; Yi J; Han BS; Xue Q; Fu ZH; Li DY
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Apr; 44(4):309-14. PubMed ID: 27112608
[TBL] [Abstract][Full Text] [Related]
8. Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients.
Zhuo ZL; Xian HP; Long Y; Liu C; Sun YY; Ma YT; Gao H; Zhao JZ; Zhao XT
Anatol J Cardiol; 2018 Feb; 19(2):123-129. PubMed ID: 29350207
[TBL] [Abstract][Full Text] [Related]
9. MDR1 gene polymorphisms and acute myeloid leukemia AML susceptibility in A Moroccan adult population: A case-control study and meta-analysis.
Kaltoum ABO; Sellama N; Hind D; Yaya K; Mouna L; Asma Q
Curr Res Transl Med; 2020 Jan; 68(1):29-35. PubMed ID: 31307954
[TBL] [Abstract][Full Text] [Related]
10. Effect of the CYP2C19 2 and 3 genotypes, ABCB1 C3435T and PON1 Q192R alleles on the pharmacodynamics and adverse clinical events of clopidogrel in Chinese people after percutaneous coronary intervention.
Tang XF; Wang J; Zhang JH; Meng XM; Xu B; Qiao SB; Wu YJ; Chen J; Wu Y; Chen JL; Gao RL; Yuan JQ; Yang YJ
Eur J Clin Pharmacol; 2013 May; 69(5):1103-12. PubMed ID: 23150151
[TBL] [Abstract][Full Text] [Related]
11. Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high maintenance-dose clopidogrel of 150 mg/day: results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidogrel According to Gene Polymorphism) study.
Jeong YH; Kim IS; Park Y; Kang MK; Koh JS; Hwang SJ; Kwak CH; Hwang JY
JACC Cardiovasc Interv; 2010 Jul; 3(7):731-41. PubMed ID: 20650435
[TBL] [Abstract][Full Text] [Related]
12. PIK3CG single nucleotide polymorphisms are associated with poor responsiveness to clopidogrel and increased risk of ischemia in patients with coronary heart disease.
Li KC; Yu SH; Zhuge BZ
Medicine (Baltimore); 2017 Sep; 96(36):e7566. PubMed ID: 28885323
[TBL] [Abstract][Full Text] [Related]
13. Associations of PER3 polymorphisms with clopidogrel resistance among Chinese Han people treated with clopidogrel.
Zheng N; Yin F; Yu Q; Zhong J; Yang J; Xu Z; Su J; Chen X
J Clin Lab Anal; 2021 Apr; 35(4):e23713. PubMed ID: 33501709
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism in
Zhang YX; Ma Y; Zhang H; Zhang WP; Yang XY
Int J Clin Pharmacol Ther; 2020 May; 58(5):254-260. PubMed ID: 32053102
[TBL] [Abstract][Full Text] [Related]
15. The association between abcb1 gene polymorphism and clopidogrel response variability in stroke ischemic: a cross sectional study.
Hidayat R; Nabilah RA; Fisher M; Aninditha T; Kurniawan M; Estiasari R; Indrawati LA; Safri AY; Mesiano T; Rasyid A; Harris S
BMC Neurol; 2024 Jun; 24(1):216. PubMed ID: 38914966
[TBL] [Abstract][Full Text] [Related]
16. Association of VEGFR-2 Gene Polymorphisms With Clopidogrel Resistance in Patients With Coronary Heart Disease.
Zhang LJ; Zhang YQ; Han X; Zhang ZT; Zhang ZQ
Am J Ther; 2016; 23(6):e1663-e1670. PubMed ID: 25738571
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis.
Mega JL; Close SL; Wiviott SD; Shen L; Walker JR; Simon T; Antman EM; Braunwald E; Sabatine MS
Lancet; 2010 Oct; 376(9749):1312-9. PubMed ID: 20801494
[TBL] [Abstract][Full Text] [Related]
18. Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention.
Mahdieh N; Rabbani A; Firouzi A; Zahedmehr A; Hoseinimoghaddam M; Saedi S; Sanati H; Basiri H; Noohi F; Rabbani B; Maleki M
Cardiovasc Toxicol; 2018 Oct; 18(5):482-491. PubMed ID: 29777510
[TBL] [Abstract][Full Text] [Related]
19. CYP2C19 genotypes and their impact on clopidogrel responsiveness in percutaneous coronary intervention.
Mejin M; Tiong WN; Lai LY; Tiong LL; Bujang AM; Hwang SS; Ong TK; Fong AY
Int J Clin Pharm; 2013 Aug; 35(4):621-8. PubMed ID: 23661171
[TBL] [Abstract][Full Text] [Related]
20. Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein.
Kurata Y; Ieiri I; Kimura M; Morita T; Irie S; Urae A; Ohdo S; Ohtani H; Sawada Y; Higuchi S; Otsubo K
Clin Pharmacol Ther; 2002 Aug; 72(2):209-19. PubMed ID: 12189368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
